Andere talen HLB Co., Ltd.

Aandelen

A028300

KR7028300002

slotkoers Korea S.E. Andere beurzen 00:00:00 28-06-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
58.500 ^KRW	-8,45%		-9,02%	+15,38%

14/05	HLB Co. rapporteert winstresultaten voor het eerste kwartaal dat eindigde op 31 maart 2024	CI
21/03	HLB Co. rapporteert resultaten voor het volledige jaar dat eindigde op 31 december 2023	CI

Andere talen

Krijg toegang tot al het nieuws: wees als eerste op de hoogte en reageer voordat de beurs dat doet!

Gratis inschrijven

HLB Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	14/05
HLB Therapeutics Co.,Ltd. announced that it has received KRW 29.99999658 billion in funding from HLB Co., Ltd.	01/04
HLB Life Science to Raise 148.5 Billion Won via Shares Issuance; Shares Decline 8%	22/03
HLB Therapeutics Co.,Ltd. announced that it expects to receive KRW 29.99999658 billion in funding from HLB Co., Ltd. and other investors	22/03
HLB Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	21/03
HLB Co., Ltd. announced that it has received KRW 60 billion in funding from a group of investors	08/03
HLB Co., Ltd. announced that it expects to receive KRW 60 billion in funding from a group of investors	04/03
Bank of Canada Holds Rates Steady; ECB Expected -2-	25/01
South Korean Shares Marginally Decline for Second Day on Profit-Booking	22/12
HLB Shareholders Endorse Transition to Main Bourse from KOSDAQ	22/12
BPH Energy Appoints HLB Mann Judd as Auditor; Shares Plunge 10%	22/11
Century Sunshine Group’s Auditor Resigns; Successor Named	17/11
Rare Earth Magnesium’s Auditor Steps Down; Successor Appointed	17/11
Jinhai International Gets New Auditor	14/11
HLB Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11
HLB, Hong Leong Islamic Bank, Cagamas Conclude MYR300 Million Green Assests Deal	04-10-23
Spenda Halts Trade Pending Court Nod for Auditor Appointment	04-09-23
Hessische Landesbahn weiter auf Wachstumskurs	04-09-23
5E Resources Appoints New Auditors	01-09-23
Elevar Therapeutics, Inc. announced that it has received KRW 58.174676146 billion in funding from HLB Co., Ltd.	11-08-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen HLB Co., Ltd.

Aandelen

A028300

KR7028300002

Andere talen

Filters